04.04.26 -- Drug Delivery Leader Best Of March

In this article, Fran DeGrazio lays out best practices for biopharma executive leadership and non-technical managers to sustain regulatory momentum for their combination product development and commercialization. Fran points to cross-functional collaboration, quality management systems, regulatory documentation, and post-market surveillance as keys to drug delivery product success. 

Solid lung tumors have a complex tumor microenvironment that creates barriers to drug delivery. Nanoparticle therapies can overcome these challenges.

Dr. Daniel Mazzaferro, founder and president at precision drug delivery technology company RheoTek Medical, joins Supplier Horizons host Tom von Gunden in a discussion of using needle-based and needle-free injection systems for precision targeting of skin cancers and other dermatological indications. The conversation includes coverage of the goals and benefits of localized rather than systemic approaches to therapeutic administration and mechanisms of action. 

Reliable drug delivery requires precision. Maintaining a robust seal throughout a product’s shelf life is essential to preserve sterility and ensure patient safety during self-administration.

This disposable pen for Semaglutide is a generic drug-device combination, designed for usability and regulatory compliance, showing comparable performance to the reference device.

Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.